Nanalysis Scientific Corp.
NSCIF
$0.1378
-$0.0022-1.57%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 30.83M | 32.30M | 33.19M | 31.62M | 29.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.83M | 32.30M | 33.19M | 31.62M | 29.11M |
| Cost of Revenue | 22.07M | 22.87M | 23.91M | 24.06M | 22.60M |
| Gross Profit | 8.76M | 9.43M | 9.28M | 7.55M | 6.52M |
| SG&A Expenses | 8.08M | 8.20M | 8.25M | 8.36M | 8.54M |
| Depreciation & Amortization | 2.89M | 2.97M | 3.18M | 3.14M | 3.13M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.41M | 34.32M | 35.74M | 35.85M | 34.62M |
| Operating Income | -2.58M | -2.02M | -2.54M | -4.23M | -5.50M |
| Income Before Tax | -8.98M | -8.88M | -9.87M | -5.37M | -8.94M |
| Income Tax Expenses | -4.80K | 15.40K | -15.60K | 725.50K | 633.10K |
| Earnings from Continuing Operations | -8.97 | -8.90 | -9.86 | -6.09 | -9.58 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 0.00 | 0.00 |
| Net Income | -8.97M | -8.90M | -9.86M | -6.09M | -9.58M |
| EBIT | -2.58M | -2.02M | -2.54M | -4.23M | -5.50M |
| EBITDA | -1.94M | -684.10K | -472.80K | -2.16M | -2.78M |
| EPS Basic | -0.08 | -0.08 | -0.09 | -0.06 | -0.09 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.03 | -0.03 | -0.04 |
| EPS Diluted | -0.08 | -0.08 | -0.09 | -0.06 | -0.09 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.03 | -0.03 | -0.04 |
| Average Basic Shares Outstanding | 453.00M | 452.49M | 442.52M | 430.88M | 419.21M |
| Average Diluted Shares Outstanding | 453.00M | 452.49M | 442.52M | 430.88M | 419.21M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |